Health and wellness products company USANA Health Sciences (NYSE: USNA) will be announcing earnings results this Tuesday after market close. Here’s what investors should know.
USANA beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $249.5 million, up 9.5% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ EBITDA estimates and full-year revenue guidance beating analysts’ expectations.
Is USANA a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting USANA’s revenue to grow 5.8% year on year to $225.2 million, a reversal from the 10.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.54 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. USANA has missed Wall Street’s revenue estimates three times over the last two years.
Looking at USANA’s peers in the consumer staples segment, some have already reported their Q2 results, giving us a hint as to what we can expect. McCormick posted flat year-on-year revenue, meeting analysts’ expectations, and Simply Good Foods reported revenues up 13.8%, in line with consensus estimates. McCormick traded up 3.6% following the results while Simply Good Foods was also up 1.7%.
Read our full analysis of McCormick’s results here and Simply Good Foods’s results here.
Investors in the consumer staples segment have had steady hands going into earnings, with share prices up 1.3% on average over the last month. USANA’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $61 (compared to the current share price of $30.35).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
